Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer Pending

2025-522883-34-00 Metastatic cervical cancer 6
An open-label dose escalation study to estimate maximum tolerated dose (MTD), identify dose-limiting toxicities (DLTs) and study pharmacokin… Pending

2024-515128-35-00 Glioblastoma 1
A Phase II, Open-Label, Single Arm, prospective, multicenter study of niraparib plus dostarlimab in patients with pleural mesothelioma posit… Pending

2024-515555-38-01 NON SMALL CELL LUNG CANCER 4
A Study to Evaluate the Safety and Tolerability of ARV-806 in Adults with Advanced Cancer that has the KRAS G12D Mutation Pending

2025-521062-10-00 KRAS G12D Mutated Advanced Solid Tumors 1
The Swedish Nationwide Clinical Trial to Facilitate Patient Access to Targeted Cancer Treatment based on Biomarker Profiling (FOCU.SE) Pending

2024-516003-16-00 Advanced Cancer 4
Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients … Pending

2024-517295-37-00 low and intermediate risk neuroblastoma 5
Perioperative Therapy with Durvalumab Plus Tremelimumab for Patients with Resectable Hepatocellular Carcinoma (HCC) - A Phase II Trial (NEOT… Pending

2023-508863-59-01 Resectable Hepatocellular Carcinoma 4
A phase 2 study of the efficacy of intratumorally administered L19IL2 or L19TNF or L19IL2/L19TNF, all in combination with systemic anti-PD1 … Pending

2024-519326-20-00 Patients with diagnosis of unresectable clinical stage 4
French prospective randomised double blind study on aspirin versus placebo in resected colon cancer with PI3K mutation stage III or II high … Pending

2024-516007-16-00 Resected colon cancer with PI3K mutation stage III or I 5
Pharmacokinetic Profiles of Subcutaneous vs. Intravenous Midazolam in Terminally Ill Patients in Palliative Care (PK-MID-PAL-study) Pending

2025-521082-26-00 Terminal illness requiring palliative care, with indica 4
A phase 1/2 study of subcutaneous blinatumomab administration in children with R/R and MRD+ B-ALL Pending

2025-521671-31-00 Relapsed/Refractory (R/R) and Minimal Residual Disease 9
A randomized phase II study of Pembrolizumab (MK-3475) as maintainance therapy in patients with unresectable stage III non-small cell lung … Pending

2024-514701-57-01 non Small Cell Lung Cancer 4
A phase II efficacy and safety study of cell-free circulating tumor DNA-guided commencement of second-line treatment in patients with DLBCL/… Pending

2024-518275-64-00 Diffuse large B-cell lymphomas (DLBCL, Diffuse large B- 4
A Phase 2, single arm Multicenter, Study testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants with Relapsed or Refrac… Pending

2025-521090-14-00 Patients with relapsed/refractory symptomatic multiple 4
Comparing intraoperative indocyanine green fluorescence imaging with standard clinical assessment for flap perfusion in head and neck recons… Pending

2025-524710-29-00 Head and neck cancer 6
BeCALM - Brentuximab vedotin in CutAneous T-cell Lymphomas (CTCL): post-allogeneic hematopoietic stem cell transplant Maintenance Pending

2025-521093-34-00 rare disease 5
A clinical study to investigate the efficacy of tarlatamab in people with extensive-stage small cell lung cancer (ES-SCLC) whose cancer has … Pending

2025-522288-13-00 Patients with pretreated extensive-stage small cell lun 4
A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treat… Pending

2025-523735-19-00 Metastatic Microsatellite Stable Colorectal Cancer 5
IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending

2023-509392-17-00 Relapsed Acute Lymphoblastic Leukemia (ALL) 5
Efficacy of the use of neoadjuvant with/without hyperthermic intraperitoneal chemotherapy in the treatment of locally advanced colon cancer Pending

2025-520471-29-00 Locally advanced adenocarcinoma of the colon and upper 5
The Synergism Or Long Duration (SOLD) Study Pending

2024-512884-30-00 breast cancer 5
Treatment of Warthin’s tumor: schlerotherapy and its natural course Pending

2024-518794-33-00 Warthin's tumor 6
RuxoTam; A phase II study to evaluate safety and efficacy of tamoxifen in combination with Ruxolitinib in patients with myelofibrosis Pending

2024-510926-19-00 Myelofibrosis 4
PROSPECTIVE RANDOMISED CLINICAL TRIAL TO EVALUATE THE EARLY RECURRENCE RATE IN NON-MUSCLE INVASIVE BLADDER CANCER BETWEEN THE USE OF CHEMOHY… Pending

2024-519890-21-00 Non-muscle invasive bladder cancer 11